Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib

• Main Authors: Krause G (Author), Hassenrück F (Author), Hallek M (Author)
• 格式: 圖書
• 出版: Dove Medical Press, 2018-08-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Günter Krause, Floyd Hassenrück, Michael Hallek Department I of Internal Medicine, University of Cologne, Center of Integrated Oncology Köln Bonn, Cologne Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany Abstract: On the occasion of its recent...